Neon Therapeutics' Series B - II Round

Neon Therapeutics raised a round of funding on December 05, 2017.

Neon Therapeutics is an immuno-oncology company focused on developing novel therapeutics leveraging neoantigen biology to treat cancer. A neoantigen-based product engine allows Neon to develop multipl…

Articles about Neon Therapeutics' Series B - II Round: